Skip to main content

Table 2 Concentrations of total and HMWA in patients with and without the metabolic syndrome

From: Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance

 

Total adiponectin

(μg/ml)

P

HMWA

(μg/ml)

P

ATP criteria

    

All (n = 269)

    

Metabolic syndrome (n = 77)

7.26 [3.57]

0.006

4.10 [3.07]

0.007

No metabolic syndrome (n = 192)

8.91 [4.84]

 

5.05 [4.03]

 

Men (n = 101)

    

Metabolic syndrome (n = 30)

6.44 [2.94]

0.183

3.25 [2.13]

0.245

No metabolic syndrome (n = 71)

7.32 [2.65]

 

3.50 [3.00]

 

Women (n = 168)

    

Metabolic syndrome (n = 47)

8.68 [4.58]

0.024

4.60 [5.00]

0.037

No metabolic syndrome (n = 121)

10.06 [4.91]

 

5.80 [4.20]

 

IDF criteria

    

All (n = 269)

    

Metabolic syndrome (n = 102)

7.27 [3.39]

< 0.001

3.95 [2.48]

< 0.001

No metabolic syndrome (n = 167)

9.11 [4.98]

 

5.40 [4.40]

 

Men (n = 101)

    

Metabolic syndrome (n = 45)

6.68 [2.79]

0.123

3.20 [1.80]

0.114

No metabolic syndrome (n = 56)

7.52 [2.93]

 

3.55 [3.48]

 

Women (n = 168)

    

Metabolic syndrome (n = 57)

8.68 [4.33]

0.002

4.60 [4.55]

0.007

No metabolic syndrome (n = 111)

10.48 [4.71]

 

6.20 [4.40]

 
  1. Values are medians [IQR]. Number of subjects in each group is indicated in parentheses.